Alger Associates Discloses 2,358,940-Share Position in CryoPort (CYRX)
Rhea-AI Filing Summary
Alger Associates, Inc. filed an amendment to Schedule 13G reporting beneficial ownership of 2,358,940 shares of CryoPort, Inc. common stock, representing 4.7% of the outstanding class. The filing states Alger Associates has sole voting and sole dispositive power over these shares and that the securities are held in the ordinary course of business, not for the purpose of changing or influencing control. The filing identifies Fred Alger Management, LLC and Alger Group Holdings as related entities that manage accounts holding the securities.
Positive
- Transparent disclosure of beneficial ownership and related-affiliate structure
- Sole voting and dispositive power over 2,358,940 shares provides clear voting accountability
Negative
- Stake is below 5%, limiting likelihood of material influence on corporate control
Insights
TL;DR: Disclosure shows a 4.7% stake with full voting and dispositive authority, indicating a meaningful passive position below the 5% reporting concern.
Alger Associates reports ownership of 2,358,940 shares and affirms ordinary-course holdings rather than an activist intent. The sole voting and dispositive power means the firm can make voting decisions, but at 4.7% the stake remains below the 5% mark that often triggers additional investor scrutiny or strategic expectations. This appears to be a portfolio position managed via affiliated investment vehicles.
TL;DR: The filing documents control over votes for a sub-5% position, so governance impact is limited but vote aggregation could matter in close matters.
While Alger Associates asserts sole voting power over 2,358,940 shares, the sub-5% ownership level constrains material influence on corporate control. The certification that holdings are not intended to change control reduces concerns about an imminent proxy campaign. Related-entity disclosures clarify fund and adviser structure, improving transparency for governance assessments.